Ulva Lactuca Ulvan Structural and Biomedical Properties

A 263.5 KB document authored by Sonalismita Mahapatra, last updated on 2026-05-21. It details the extraction and characterization of ulvan polysaccharide from Ulva lactuca, reporting results from in vitro assays for antimicrobial, antibiofilm, antidiabetic, and anticancer activities.

Use Cases

• Assess potential natural antimicrobial agents based on reported MIC values against bacterial and Candida strains.
• Evaluate antibiofilm compounds based on described inhibition of exopolysaccharide production and microbial adherence.
• Screen for anticancer drug candidates based on cytotoxicity data against human skin cancer (A431) cells.
• Investigate antidiabetic agents based on reported α-amylase inhibitory activity.
• Study the structure-property relationships of sulfated polysaccharides based on spectral and biochemical characterization data.

Strengths

• Reported specific bioactivity metrics, including MICs in the range of 50 to 90 µg/mL and an IC50 of 78.43 µg/mL for α-amylase inhibition.
• Detailed characterization data is provided, including thermal stability up to 600°C and biochemical composition analysis.
• The document is openly licensed under CC-BY-4.0.

Limitations

• The dataset is a single 263.5 KB DOC file, indicating a very limited scope focused on one study's results.
• Row count and column-level documentation are absent; data is embedded in a narrative document.
• Freshness should be verified as the last update date is in the future (2026-05-21).

Provenance

Source

figshare

Collection Method

Hot water extraction and purification from Ulva lactuca, followed by spectral analysis and in vitro assays.

Freshness

Last updated 2026-05-21 04:37:09